Skip to content

Educ'Avk: Recommendations for the Antivitamin K's Gestion

Implication of Patient in the Making Ready of Recommendations for the Antivitamin K's Gestion in Case of Thrombosis Embolic Venous's Illness. Randomised Study for Clinical Validation.

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00227097
Enrollment
300
Registered
2005-09-27
Start date
2002-12-31
Completion date
2004-12-31
Last updated
2006-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AVK Treatment

Keywords

therapeutic education, thrombi embolic disease

Brief summary

The objective of the project Educ'Avk, is to document the efficacy of a strategy combining a specific follow up-notebook and education of attending patient with a pedagogic support, comparatively to an usual education on the impact of clinical events at three months (minor or major hemorrhagic events + recurrence of thrombi-embolic's disease).

Detailed description

Standard strategies for the implementation of recommendations are exclusively focused on practitioners. But often they do not appear to be effective (insufficient time accorded per patient, lack of training…). However some qualitative surveys have shown the benefit of a greater role on the part patient in the process of transmitting recommendations through the practitioner. In this study, patient education is begun by the angiologist or a pharmacy student under the responsibility of the hospital investigator. Follow-up is realized by the patient's general practitioner. More patient involvement in the realization of the recommendations could increase the proportion of practitioners who follow the recommendations and decrease the iatrogenicity of antivitamin K (AVK).

Interventions

BEHAVIORALEducation Notebook for anticoagulant treatment

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Able to receive benefit sanitary educational act * Able to be followed up during three months * Acute episode of a venous's thrombi embolic illness (venous's thrombosis distal or proximal deep and/or lung embolism) * A.V.K. treatment for a period of at least three months * Return to residence (included return to retreat residence no medicalize) * Informed consent form signed

Exclusion criteria

* Distal venous thrombosis limited muscular vein without lung embolism * Contra-indication of to an A.V.K. treatment * Difficult comprehension of the french language * Trouble of visual acuity * Trouble of superior function incompatible with an educational's act sanitary * Psycho-social instability incompatible with a regular follow-up of three months (without fixed residence, addictive lapsed) * Impossibility to return to residence (the return in retreat residence no medicalize is considered as a return to residence) * Psychiatric pathology not compensated * Life expectancy less than three months * Refusal of participation in the study * Participation in another clinical study * Anterior inclusion in the study

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026